News

Presept is a multi-center, multi-national clinical study sponsored by Epigenomics prospectively evaluating the clinical performance of the company’s proprietary biomarker, Septin 9, for colorectal cancer population wide screening

Basilea Pharmaceuticals will co-promote the drug in Canada under the trade name Zeftera with its local partner Janssen-Ortho. Ceftobiprole is currently under review by regulatory authorities in the

The study did not achieve statistical significance on either of its primary endpoints – cognition and activities of daily living. Peter Meldrum, president and CEO of Myriad Genetics,

Enbrel 25mg Syringe 0.5mL for SC Injection is a new formulation of the existing Enbrel 25mg for SC Injection, with the drug pre-filled into the syringe. According to

Panitumumab is a fully-human monoclonal antibody which binds to epidermal growth factor receptor and suppresses tumor growth. It shows a low incidence of allergic reaction upon and also

Dronabinol is the generic version of Solvay Pharmaceuticals’s Marinol CIII capsules, indicated to treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond

Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor’s proprietary compound library, and plate and replicate these compounds for a

Golimumab, Centocor’s next-generation human anti-TNF-alpha monoclonal antibody, is being studied as an every four week subcutaneous injection and is also being studied as an intravenous (IV) infusion therapy.

The companies also terminated the Schering-Plough and Merck Pharmaceuticals respiratory joint venture, which was formed in May 2000 to develop and market a fixed-combination product that would combine